DE602005003315D1 - BenzoÄbÜpyranoÄ3,2-hÜacridin-7-one-zimtsäurederivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen diese enthaltend - Google Patents
BenzoÄbÜpyranoÄ3,2-hÜacridin-7-one-zimtsäurederivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen diese enthaltendInfo
- Publication number
- DE602005003315D1 DE602005003315D1 DE602005003315T DE602005003315T DE602005003315D1 DE 602005003315 D1 DE602005003315 D1 DE 602005003315D1 DE 602005003315 T DE602005003315 T DE 602005003315T DE 602005003315 T DE602005003315 T DE 602005003315T DE 602005003315 D1 DE602005003315 D1 DE 602005003315D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- aryl
- optionally substituted
- halo
- benzo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 13
- 125000003118 aryl group Chemical group 0.000 abstract 7
- 125000005843 halogen group Chemical group 0.000 abstract 6
- -1 acridin-7-one cinnamate compounds Chemical class 0.000 abstract 4
- 125000005842 heteroatom Chemical group 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 239000002585 base Substances 0.000 abstract 2
- 125000005605 benzo group Chemical group 0.000 abstract 2
- 150000004677 hydrates Chemical class 0.000 abstract 2
- 125000002950 monocyclic group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 229910003827 NRaRb Inorganic materials 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0413682 | 2004-12-22 | ||
FR0413682A FR2879600B1 (fr) | 2004-12-22 | 2004-12-22 | Nouveaux derives cinnamates de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
DE602005003315D1 true DE602005003315D1 (de) | 2007-12-27 |
DE602005003315T2 DE602005003315T2 (de) | 2008-09-25 |
Family
ID=34954114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005003315T Expired - Fee Related DE602005003315T2 (de) | 2004-12-22 | 2005-12-21 | BenzoÄbÜpyranoÄ3,2-hÜacridin-7-one-zimtsäurederivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen diese enthaltend |
Country Status (26)
Country | Link |
---|---|
US (1) | US7144891B2 (de) |
EP (1) | EP1674101B1 (de) |
JP (1) | JP2006176525A (de) |
KR (1) | KR100742060B1 (de) |
CN (1) | CN1796387A (de) |
AT (1) | ATE378050T1 (de) |
AU (1) | AU2005247032A1 (de) |
BR (1) | BRPI0506019A (de) |
CA (1) | CA2529630A1 (de) |
CY (1) | CY1107100T1 (de) |
DE (1) | DE602005003315T2 (de) |
DK (1) | DK1674101T3 (de) |
EA (1) | EA010094B1 (de) |
ES (1) | ES2297648T3 (de) |
FR (1) | FR2879600B1 (de) |
HR (1) | HRP20070524T3 (de) |
MA (1) | MA27965A1 (de) |
MX (1) | MXPA05013993A (de) |
MY (1) | MY138045A (de) |
NO (1) | NO20056091L (de) |
NZ (1) | NZ544315A (de) |
PL (1) | PL1674101T3 (de) |
PT (1) | PT1674101E (de) |
SG (1) | SG123675A1 (de) |
SI (1) | SI1674101T1 (de) |
ZA (1) | ZA200510323B (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2902792A1 (fr) * | 2006-06-21 | 2007-12-28 | Servier Lab | Nouveaux derives cinnamates de tetrahydro-7h-pyrano(2,3-c)acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2772765B1 (fr) * | 1997-12-19 | 2000-03-17 | Adir | Nouveaux derives de l'acronycine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2795071B1 (fr) * | 1999-06-16 | 2001-07-27 | Adir | Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US7056929B2 (en) * | 2001-07-25 | 2006-06-06 | Les Laboratoires Servier | Benzo[b]pyrano[3,2-h]acridin-7-one compounds |
FR2827864B1 (fr) * | 2001-07-25 | 2005-09-16 | Servier Lab | Nouveaux derives de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2004
- 2004-12-22 FR FR0413682A patent/FR2879600B1/fr not_active Expired - Fee Related
-
2005
- 2005-12-01 SG SG200507683A patent/SG123675A1/en unknown
- 2005-12-07 MA MA28637A patent/MA27965A1/fr unknown
- 2005-12-09 CA CA002529630A patent/CA2529630A1/fr not_active Abandoned
- 2005-12-20 MY MYPI20056024A patent/MY138045A/en unknown
- 2005-12-20 ZA ZA200510323A patent/ZA200510323B/en unknown
- 2005-12-20 MX MXPA05013993A patent/MXPA05013993A/es unknown
- 2005-12-21 NO NO20056091A patent/NO20056091L/no not_active Application Discontinuation
- 2005-12-21 AT AT05292744T patent/ATE378050T1/de not_active IP Right Cessation
- 2005-12-21 PL PL05292744T patent/PL1674101T3/pl unknown
- 2005-12-21 SI SI200530108T patent/SI1674101T1/sl unknown
- 2005-12-21 DE DE602005003315T patent/DE602005003315T2/de not_active Expired - Fee Related
- 2005-12-21 ES ES05292744T patent/ES2297648T3/es active Active
- 2005-12-21 US US11/313,386 patent/US7144891B2/en not_active Expired - Fee Related
- 2005-12-21 EP EP05292744A patent/EP1674101B1/de active Active
- 2005-12-21 EA EA200501845A patent/EA010094B1/ru unknown
- 2005-12-21 PT PT05292744T patent/PT1674101E/pt unknown
- 2005-12-21 NZ NZ544315A patent/NZ544315A/en unknown
- 2005-12-21 DK DK05292744T patent/DK1674101T3/da active
- 2005-12-22 AU AU2005247032A patent/AU2005247032A1/en not_active Abandoned
- 2005-12-22 CN CNA2005101328156A patent/CN1796387A/zh active Pending
- 2005-12-22 JP JP2005369129A patent/JP2006176525A/ja active Pending
- 2005-12-22 BR BRPI0506019-2A patent/BRPI0506019A/pt not_active IP Right Cessation
- 2005-12-22 KR KR1020050128012A patent/KR100742060B1/ko not_active IP Right Cessation
-
2007
- 2007-11-15 HR HR20070524T patent/HRP20070524T3/xx unknown
- 2007-12-19 CY CY20071101611T patent/CY1107100T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE602005003315T2 (de) | 2008-09-25 |
ATE378050T1 (de) | 2007-11-15 |
US20060135545A1 (en) | 2006-06-22 |
CA2529630A1 (fr) | 2006-06-22 |
PL1674101T3 (pl) | 2008-05-30 |
EA200501845A3 (ru) | 2006-10-27 |
NZ544315A (en) | 2006-11-30 |
HRP20070524T3 (en) | 2008-07-31 |
EA200501845A2 (ru) | 2006-06-30 |
NO20056091L (no) | 2006-06-23 |
BRPI0506019A (pt) | 2006-09-19 |
JP2006176525A (ja) | 2006-07-06 |
EA010094B1 (ru) | 2008-06-30 |
KR20060072093A (ko) | 2006-06-27 |
MA27965A1 (fr) | 2006-07-03 |
CY1107100T1 (el) | 2012-10-24 |
CN1796387A (zh) | 2006-07-05 |
DK1674101T3 (da) | 2008-03-03 |
ZA200510323B (en) | 2006-12-27 |
SI1674101T1 (sl) | 2008-04-30 |
EP1674101B1 (de) | 2007-11-14 |
MY138045A (en) | 2009-04-30 |
ES2297648T3 (es) | 2008-05-01 |
EP1674101A1 (de) | 2006-06-28 |
AU2005247032A1 (en) | 2006-07-06 |
US7144891B2 (en) | 2006-12-05 |
KR100742060B1 (ko) | 2007-07-23 |
FR2879600B1 (fr) | 2007-02-09 |
PT1674101E (pt) | 2007-12-17 |
MXPA05013993A (es) | 2006-06-21 |
FR2879600A1 (fr) | 2006-06-23 |
SG123675A1 (en) | 2006-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69828445D1 (de) | Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
BR0008770A (pt) | Derivado de pirimidina, processo para a preparação de um derivado de pirimidina, processo para a produção de um efeito anti-câncer em um animal de sangue quente, uso de um derivado de pirimidina, e, composição farmacêutica | |
ATE126216T1 (de) | Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung. | |
BR0317294A (pt) | Composto, formulação farmacêutica, uso de um composto, métodos de prevenção e/ou tratamento de condições associadas com a glicogênio sintase quinase-3 e de prevenção e/ou tratamento de doenças, e, uso dos intermediários | |
RS49850B (sr) | Derivati 1,4-benzotiazepin-1,1-dioksida supstituisani radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena | |
BR0308056A (pt) | Composto, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto | |
NO20085078L (no) | Nye forbindelser | |
BRPI0407506A (pt) | compostos para o tratamento de distúrbios metabólicos, seu uso e composição farmacêutica compreendendo os mesmos | |
AR005827A1 (es) | Compuesto derivado de nucleosidos aciclicos, composicion farmaceutica que lo comprende, uso del mismo en la preparacion de un medicamento y su metodo de preparacion | |
ATE10804T1 (de) | Ein diphenylhydantoin-derivat enthaltende pharmazeutische zusammensetzung, verwendete derivate und ihre herstellung. | |
NO20044810L (no) | Farmasoytisk formulering med oyeblikkelig frigjoring | |
AR036176A1 (es) | Un derivado de fenil-acetamido-tiazol, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un producto o kit que los comprende, y un metodo que utiliza dicho derivado | |
NO20060277L (no) | Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger | |
HUT59124A (en) | Process for producing 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxane derivatives and pharmaceutical compositions comprising such derivatives as active ingredient | |
DE602005003315D1 (de) | BenzoÄbÜpyranoÄ3,2-hÜacridin-7-one-zimtsäurederivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen diese enthaltend | |
BG106520A (en) | Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity | |
BR9917315A (pt) | Composições medicinais para liberação imediata para uso oral | |
MX9405111A (es) | Nuevos derivados de (1-fenil-1-heterociclil)metanol y(1-fenil-1-heterociclil-metilamina). | |
WO2001017955A3 (en) | Hydroxyacetamidobenzenesulphonamide derivatives | |
AR020294A1 (es) | COMPUESTOS DERIVADOS DE 1-TRIFLUOROMETIL-4-HIDROXI-7-PIPERIDINIL-AMINOMETILCROMANO, COMPOSICION FARMACEUTICA Y USO EN LA PREPARACIoN DE MEDICAMENTOS. | |
AR046212A1 (es) | Derivados de 2-fenilbenzofurano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
RU97102333A (ru) | Производные диарилалканов, содержащие алициклическую группу, их получение и терапевтическое и профилактическое применение | |
NO20002315L (no) | Nye 1-aza-2-alkyl-6-aryl-cykloalkanforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
SE8903313L (sv) | Nya 2-metoxikarbonyl-substituerade n,n'-di-(trimetoxibensoyl)-piperaziner, foerfarande foer framstaellning daerav och terapeutiska foereningar innehaallande dem | |
DE3168174D1 (en) | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |